Allergan Australia Pty Ltd v Self Care IP Holdings Pty Ltd (No 2)

JurisdictionAustralia Federal only
Judgment Date05 March 2021
Neutral Citation[2021] FCA 185
CourtFederal Court
Date05 March 2021


Federal Court of Australia


Allergan Australia Pty Ltd v Self Care IP Holdings Pty Ltd (No 2) [2021] FCA 185

File numbers:


NSD 15 of 2017NSD 1802 of 2017



Judgment of:

STEWART J



Date of judgment:

5 March 2021



Catchwords:

COSTS – where costs were previously determined – whether costs order can be revisited pursuant to the slip rule in r 39.05(h) of the Federal Court Rules 2011 (Cth) – whether there was “an error arising in a judgment or order from an accidental slip or omission” – where costs had not previously been sought on an indemnity basis – where multiple Calderbank offers were made – whether unsuccessful party would have been in a better position had it accepted the offers – whether offers were unreasonably or impudently rejected – no basis to award costs on an indemnity basis – slip rule applied – previous costs order vacated – rough and ready allowance made for issues on which predominantly successful party was unsuccessful – costs awarded on a lump sum basis to be quantified by agreement or the Registrar



Legislation:

Competition and Consumer Act 2010 (Cth) Sch 2 (Australian Consumer Law)

Federal Court of Australia Act 1976 (Cth) s 43

Federal Court Rules 2011 (Cth) rr 22.03, 39.05(h), 39.05(e)

Therapeutic Goods Act 1989 (Cth)



Cases cited:

Allergan Australia Pty Ltd v Self Care IP Holdings Pty Ltd[2020] FCA 1530

Anchorage Capital Partners Pty Ltd v ACPA Pty Ltd (No. 2) [2018] FCAFC 112

Calderbank v Calderbank[1975] 3 WLR 586

CGU Insurance Ltd v Corrections Court of Australia Superannuation Ltd [2008] FCAFC 173

Chevron Australia Holdings Pty Ltd v Cmr of Taxation (No 5) [2015] FCA 1310

Construction, Forestry, Mining and Energy Union v Mammoet Australia Pty Ltd (No 2) [2012] FCA 1404

Cretazzo v Lombardi (1975) 13 SASR 4

DJL v The Central Authority[2000] HCA 17;201 CLR 226

EMI Songs Australia Pty Ltd v Larrikin Music Publishing Pty Ltd [2011] FCAFC 92

Hammond v Quayeyeware Pty Ltd, in the matter of Quayeyeware Pty Ltd[2019] FCA 2207; 141 ACSR 434

Hancock Prospecting Pty Ltd v Rinehart (No 3)[2021] FCAFC 23

Marmax Investments Pty Ltd v RPR Maintenance Pty Ltd (No 2) [2015] FCAFC 155

Notaras v Barcelona Pty Ltd (No 2)[2019] FCA 617

Owston Nominees No 2 Pty Limited v Branir Pty Ltd [2003] FCA 629; 129 FCR 558

Paciocco v Australia and New Zealand Banking Group Ltd (No 2) [2017] FCAFC 146; 253 FCR 403

Pantzer v Wenkart[2007] FCAFC 27

Polygram Records Inc v Raben Footwear Pty Ltd [1996] AIPC 91-284; 140 ALR 617

SZCZF v Minister for Immigration and Citizenship [2009] FCA 208; 107 ALD 138

Tropicana Ltd v Australasia Corporate Services Pty Ltd [2011] FCA 684

Victoria v Sportsbet Pty Ltd (No 2) [2012] FCAFC 174

Federal Court of Australia, Costs Practice Note (GPN-COSTS), 25 October 2016



Division:

General Division



Registry:

New South Wales



National Practice Area:

Intellectual Property



Sub-area

Trade Marks



Number of paragraphs:

72



Date of hearing:

Determined on the papers



NSD 15 of 2017




Counsel for the Applicants/Cross-Respondent:

S J Goddard and E E Whitby



Solicitor for the Applicants/Cross-Respondent:

Griffith Hack Lawyers



Counsel for the Respondents/Cross-Claimant:

A R Lang and J E McKenzie



Solicitor for the Respondents/Cross-Claimant:

MinterEllison



NSD 1802 of 2017




Counsel for the Appellant:

S J Goddard and E E Whitby



Solicitor for the Appellant:

Griffith Hack Lawyers



Counsel for the Respondent:

A R Lang and J E McKenzie



Solicitor for the Respondent:

MinterEllison





ORDERS


NSD 15 of 2017

BETWEEN:

ALLERGAN AUSTRALIA PTY LTD (ACN 000 612 831)

First Applicant


ALLERGAN INC

Second Applicant


AND:

SELF CARE IP HOLDINGS PTY LTD (ACN 134 308 151)

First Respondent


SELF CARE CORPORATION PTY LTD (ACN 132 213 113)

Second Respondent


SONIA AMOROSO

Third Respondent




AND BETWEEN:

SELF CARE IP HOLDINGS PTY LTD (ACN 134 308 151) (and another named in the Schedule)

First Cross-Claimant


AND:

ALLERGAN INC (and another named in the Schedule)

First Cross-Respondent



order made by:

STEWART J

DATE OF ORDER:

5 March 2021



THE COURT ORDERS THAT:


  1. The applicants are liable to the respondents for 90% of their party/party costs in this proceeding and proceeding NSD1802/2017.

  2. Failing agreement between the parties on the quantification of those costs within 28 days of these orders, the costs to be determined on a lump sum basis by a Registrar of this Court.



Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.


ORDERS


NSD 1802 of 2017

BETWEEN:

ALLERGAN INC

Appellant


AND:

SELF CARE IP HOLDINGS PTY LTD (ACN 134 308 151)

Respondent



order made by:

STEWART J

DATE OF ORDER:

5 March 2021



THE COURT ORDERS THAT:


  1. Order 2 of the orders of 22 October 2020 is set aside.

  2. Costs of this proceeding are costs in proceeding NSD15/2017.





Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.

REASONS FOR JUDGMENT

STEWART J:

Introduction
  1. This judgment concerns the costs of the proceedings which, aside from costs dealt with here, I have previously determined. As there is no need for present purposes to distinguish between the various applicants or the various respondents, I shall refer to them simply as Allergan (the applicants) and Self Care (the respondents).

  2. On 22 October 2020, I published reasons for judgment in these two proceedings: Allergan Australia Pty Ltd v Self Care IP Holdings Pty Ltd[2020] FCA 1530 (the first judgment). The cases are:

  1. NSD15/2017 (the main proceeding) in which Allergan advanced cases against Self Care for trademark infringement, misrepresentations contrary to the Competition and Consumer Act 2010 (Cth) Sch 2 (Australian Consumer Law) (ACL), passing-off and infringements of the Therapeutic Goods Act 1989 (Cth), and in which Self Care by cross-claim sought removal of certain trademarks from the register, or for the scope of their registration to be reduced; and

  2. NSD1802/2017 (the appeal proceeding) in which Allergan appealed against the decision of a delegate of the Registrar of Trade Marks to allow Self Care’s trade mark application in respect of FREEZEFRAME PROTOX to proceed to registration.

  1. In respect of the main proceeding, I made orders that the parties prepare consent or competing orders, in accordance with my reasons and findings, to dispose of the...

Get this document and AI-powered insights with a free trial of vLex and Vincent AI

Get Started for Free

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex
2 cases
  • Allergan Australia Pty Ltd v Self Care IP Holdings Pty Ltd
    • Australia
    • Full Federal Court (Australia)
    • 7 September 2021
    ...Australia Pty Ltd v Self Care IP Holdings Pty Ltd [2020] FCA 1530 Allergan Australia Pty Ltd v Self Care IP Holdings Pty Ltd (No 2) [2021] FCA 185 File numbers: NSD 35 of 2021 NSD 249 of 2021 Judgment of: JAGOT, LEE AND THAWLEY JJ Date of judgment: 7 September 2021 Catchwords: TRADE MARKS –......
  • Australian Securities and Investments Commission v Mitchell (No 4)
    • Australia
    • Federal Court
    • 5 November 2021
    ...Rules 2011 (Cth) rr 39.04, 39.05, 40.01, 40.02 Cases cited: Allergan Australia Pty Limited v Self Care IP Holdings Pty Limited (No 2) [2021] FCA 185 Barnes v Forty Two International Pty Limited (No 2) [2015] FCAFC 19 Endresz v The Commonwealth (2019) 273 FCR 286 Notaras v Barcelona Pty Limi......